.Regeneron is actually back with long-lasting consequence for its own LAG-3 inhibitor as well as PD-...
.AstraZeneca has shared an early check out the functionality of its own internal antibody-drug conju...
.After revealing a period 3 launch based on good midstage end results, iTeos and also GSK are eventu...
.The FDA ought to be actually even more available as well as joint to release a surge in commendatio...
.It is actually an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bic...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 trial, however the b...
.Neurocrine Biosciences' schizophrenia program pivot has stopped working. The biotech was not able t...
.Sanofi has made a late entrance to the radioligand party, spending 100 thousand europeans ($ 110 mi...
.After F2G's initial try to receive a new course of antifungal to market was thwarted due to the FDA...
.Moderna has vowed to reduce R&D investing by $1.1 billion through 2027. The selection to shrink ...